ArticleClinica chimica acta; international journal of clinical chemistry2023

Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.

Seetharaman Balasenthil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.